Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Cancers|December 23, 2023
The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 ExpressionAgreen Hadadi, Harris B Krause, Andrew Elliott, et al.
Cancer|August 11, 2023
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkersBassel Nazha, Tony Zhuang, Sharon Wu, et al.
Asian Journal of Urology|February 2, 2018
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinomaRishi R Sekar, Dattatraya Patil, Yoram Baum, et al.
Cancer Treatment and Research Communications|May 24, 2021
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinibDylan J Martini, Meredith R Kline, Yuan Liu, et al.
The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.
Cancer Medicine|February 27, 2020
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitorsJulie M Shabto, Dylan J Martini, Yuan Liu, et al.
Clinical Genitourinary Cancer|July 16, 2023
Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808Bradley C Carthon, Se Eun Kim, David F McDermott, et al.
Cancer|July 3, 2024
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiationDylan J Martini, Katherine B Case, Derrik Gratz, et al.
Therapeutic Advances in Medical Oncology|February 13, 2025
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitorsAhmet Yildirim, Mengting Wei, Yuan Liu, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.
Pageof 6